Patents by Inventor Robert E. Donahue

Robert E. Donahue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA encoding the human cytokine, interleukin-9
    Patent number: 5734037
    Abstract: This invention provides a novel human erythropoietic growth factor and processes for producing it by recombinant DNA genetic engineering techniques.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: March 31, 1998
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Yu-Chung Yang, Agnes Brennan Ciarletta, Susan Teresa Ricciardi, Steven C. Clark, Robert E. Donahue
  • DNA encoding the human cytokine, interleukin-9
    Patent number: 5580753
    Abstract: The invention involves DNA molecules which encode a human protein of 144 amino acids, referred to as interleukin-9, or IL-9. The protein is an erythropoietic growth factor. Also disclosed are processes for producing the IL-9 protein via genetic engineering techniques.
    Type: Grant
    Filed: April 27, 1990
    Date of Patent: December 3, 1996
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Yu-Chung Yang, Agnes B. Ciarletta, Susan T. Ricciardi, Steven C. Clark, Robert E. Donahue
  • Methods of treating pancytopenia and AIDS by co-administering EPO and colony stimulating factors
    Patent number: 5198417
    Abstract: Disclosed herein is the treatment of patients suffering from AIDS-type disease with erythropoietin alone or together with a colony stimulating factor, and/or an anti-viral agent and/or IL-2.
    Type: Grant
    Filed: November 7, 1989
    Date of Patent: March 30, 1993
    Assignee: Genetics Institute, Inc.
    Inventor: Robert E. Donahue
  • Method of inducing leukocytosis with a combination of IL-3 and GM-CSF
    Patent number: 5032395
    Abstract: An improved method for inducing leukocytosis in a primate is disclosed. The method includes co-administering IL-3 in conjunction with GM-CSF, such that the leukocyte count in the primate is synergistically raised.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: July 16, 1991
    Assignee: Genetics Institute, Inc.
    Inventors: Steven C. Clark, Agnes B. Ciarletta, Yu-Chung Yang, Robert E. Donahue
  • Treatment of AIDS-type disease
    Patent number: 4921837
    Abstract: Disclosed herein is the treatment of patients suffering from AIDS-type disease with a colony stimulating factor alone or together with erythropoietin, and/or an anti-viral agent and/or IL-2.
    Type: Grant
    Filed: July 24, 1987
    Date of Patent: May 1, 1990
    Assignee: Genetics Institute Inc.
    Inventor: Robert E. Donahue